FYERS
Home
/
Stocks
/
Profit Loss
/
Sudarshan Pharma Industries Profit & Loss

Sudarshan Pharma Industries Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
₹174 Cr₹221 Cr₹168 Cr₹169 Cr₹145 Cr₹162 Cr₹116 Cr₹129 Cr₹99 Cr
₹1 Cr₹4 Cr₹2 Cr₹2 Cr₹1 Cr₹84 L₹51 L₹32 L₹98 L
₹176 Cr₹225 Cr₹170 Cr₹171 Cr₹146 Cr₹162 Cr₹116 Cr₹129 Cr₹100 Cr
₹160 Cr₹202 Cr₹158 Cr₹161 Cr₹135 Cr₹146 Cr₹108 Cr₹116 Cr₹98 Cr
₹17 Cr₹24 Cr₹12 Cr₹11 Cr₹12 Cr₹17 Cr₹8 Cr₹13 Cr₹3 Cr
₹8 Cr₹8 Cr₹6 Cr₹6 Cr₹6 Cr₹4 Cr₹4 Cr₹4 Cr₹4 Cr
₹8 Cr₹16 Cr₹5 Cr₹4 Cr₹5 Cr₹10 Cr₹4 Cr₹8 Cr-₹2 Cr
₹6 Cr₹11 Cr₹4 Cr₹4 Cr₹4 Cr₹7 Cr₹3 Cr₹6 Cr-₹1 Cr

Share Price Live Stats

Open (₹)40.00
Volume (₹)24,000.00
High (₹)40.00
Upper Circuit42.11
Low (₹)39.45
Lower Circuit38.11
Prev Close40.11
52W High (₹)42.79
Price39.47
52W Low (₹)18.50

Share Market Cap & Key Ratios Overview

M.Cap (₹)1004.90 Cr
Div. Yield (%)0.00
PE Ratio40.00
Debt to Equity1.34
Price to Book5.76
Book Value5.30
EPS (TTM)0.99
Face Value1.00
ROE (%)13.33

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMA-ANSE
DIVISLAB-ANSE
TORNTPHARM-ANSE
ZYDUSLIFE-ANSE
CIPLA-ANSE
LAURUSLABS-ANSE
AUROPHARMA-ANSE
LUPIN-ANSE
DRREDDY-ANSE
MANKIND-ANSE
SUDARSHAN-MNSE
LTP
1W Low
1W High
Market cap (₹)
1864-35 (-1.84%)
1840.70
1907.35
4,48,316Cr
9405+305 (3.35%)
9109.80
10000
2,51,737Cr
4928.4+78.4 (1.62%)
4830
4999
1,87,594Cr
1118-3 (-0.27%)
1110.10
1167.20
1,12,618Cr
1380-5 (-0.36%)
1363.95
1397.05
1,10,515Cr
1936+96 (5.22%)
1826.95
1981
1,04,456Cr
1669+15.7 (0.95%)
1638.65
1703.25
97,239Cr
2075-36 (-1.71%)
2060.55
2132.45
95,660Cr
1140.8-13.2 (-1.14%)
1135.20
1161
95,421Cr
2246-82.55 (-3.55%)
2238.95
2330
93,596Cr
39.47+0.05 (0.13%)
39.45
42.50
1,021Cr

Key Highlights of Sudarshan Pharma Industries Ltd’s P&L

In 2025-03-31, Sudarshan Pharma Industries Ltd reported total revenue of ₹507.57Cr, compared with ₹466.15Cr in 2024-03-31, reflecting Sudarshan Pharma Industries Ltd turnover.

Depreciation was ₹2.22Cr and finance costs were ₹15.77Cr in 2025-03-31

Profit Before Tax (PBT) has been ₹21.63Cr in 2025-03-31 as compared to ₹15.23Cr in 2024-03-31.

Net Profit (PAT) was ₹15.96Cr in 2025-03-31 compared with ₹11.46Cr in 2024-03-31.

Earnings per share (EPS) were ₹0.66 in 2025-03-31, compared with ₹4.76 in 2024-03-31.